Stem Cell Channel (Audio)

While exercise helps us stay healthy, what is happening on the molecular level? Matthew A. Romero, Ph.D., shares his work to understand how muscle in general and other cells specifically are transcriptionally regulated by exercise and how this affects their general behavior and how this is impacted by diseases such as obesity.

Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39033]

Gaia Navarino shares her work on disorder-causing genetic mutations at the system, cellular and molecular level. With a focus on autism spectrum disorder, she explains techniques used to identify common pathophysiological mechanisms in ASD and how that could provide a framework for the development of effective pharmacological therapies. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38325]

Ali H. Brinvanlou, Ph.D., shares his work using in vitro attached human embryos and genome-edited synthetic embryos derived from human embryonic stem cells to learn the molecular, cellular, and embryological basis of early human development. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38324]

Have questions about publishing in academic journals? Sheila Chari, Ph.D., editor in chief of Cell Stem Cell, explains the process from pre-submission through publication. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38722]

Tim Fenton, Ph.D., University of Southampton, shares his work on the roles of APOBEC3 genes. Hear how he is investigating APOBEC regulation and function in keratinocytes. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38724]

How do visions and norms of scientific progress inform, encourage or constrain democratic governance of science? How do questions of warrant, purpose, and benefit get asked and answered? Andy Murray, Ph.D., sits down with Carrie Wolinetz, Ph.D., National Institutes of Health (NIH), Maria Millan, M.D, California Institute for Regenerative Medicine (CIRM, Derek Thompson, The Atlantic, and Sheila Jasanoff, J.D., Ph.D., Harvard University, to explore these questions and more. Series: "Stem Cell Channel" [Science] [Show ID: 38731]

How do we set practical policies that allow scientific discovery to thrive while keeping an eye to risks and benefits for all? Carrie Wolinetz, Ph.D.,

National Institutes of Health (NIH), looks at current and past policy and shares her insights on the democratic governance of science. Series: "Stem Cell Channel" [Science] [Show ID: 38745]

How do structures and practices of privatization and commercialization affect capacities for deliberating and defining limits? How do questions of purpose, desirability, and public good relate to the prioritization of commercialization and profit? What means, formal and informal, exist for setting limits or seeking alignment between public and private interests? Krishanu Saha, Ph.D, Rosemarie Garland-Thomson, Ph.D., Reuven Brandt, Ph.D., and J. Benjamin Hurlbut, Ph.D., engage in a lively discussion of cosmopolitan ethics. Series: "Stem Cell Channel" [Public Affairs] [Humanities] [Show ID: 38730]

How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]

The identity of somatic and pluripotent cells can be epigenetically reprogrammed and forced to adapt a new functional cell state by different methods and distinct combinations of exogenous factors. The aspiration to utilize such in vitro reprogrammed pluripotent and somatic cells for therapeutic purposes necessitates understanding of the mechanisms of reprogramming and differentiation and elucidating the extent of equivalence of the in vitro derived cells to their in vivo counterparts. Jacob (Yaqub) Hanna, M.D., Ph.D., presents his group’s recent advances toward understanding these fundamental questions and further details ongoing efforts to generate developmentally unrestricted human naive pluripotent cells with embryonic and extra-embryonic developmental potential. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38323]